AdMare and AmorChem back Neurasic Therapeutics' launch
AdMare BioInnovations and Canadian life sciences venture capital firm AmorChem have invested in the launch of Montreal-based Neurasic Therapeutics.
4 June 2020•5 mins read
AdMare BioInnovations and Canadian life sciences venture capital firm AmorChem have invested in the launch of Montreal-based Neurasic Therapeutics.
Bites raises $40m Series A round to expand frontline worker learning platform
29 October 2026 · 7 mins read
OCIO Cerity seeks proof of exits as clients raise bar for venture funds
29 October 2026 · 4 mins read
Matter taps LPs that bring more than money for oversubscribed Fund II
28 October 2026 · 5 mins read
BackingMinds raises €50m for Fund III, focused on Nordic start-ups
26 October 2026 · 3 mins read
Singapore VC plants flag in Ohio in search of US investors
26 October 2026 · 6 mins read
New AI threats are fueling VC investment in cybersecurity
22 October 2026 · 4 mins read
Inspired Capital holds quick close on $450m for Fund IV
20 October 2026 · 4 mins read
